Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
Recruiting
Observational Study
Myelodysplastic Syndromes
Leukemia, Myeloid, Acute
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 6,990 (estimated)
- Sponsor
- Groupe Francophone des Myelodysplasies · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female
* Age \> 18 years
* Patients with myelodysplastic syndrome and therapy-related acute myeloid leukemia
* Able and willing to provide written informed consent
Exclusion Criteria:
* Age \<18 years
* Patient is unwilling or unable to give consent
Contacts